Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 252

1.

Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials.

Hallemeier CL, Zhang P, Pisansky TM, Hanks GE, McGowan DG, Roach M 3rd, Zeitzer KL, Firat SY, Husain SM, D'Souza DP, Souhami L, Parliament MB, Rosenthal SA, Lukka HR, Rotman M, Horwitz EM, Miles EF, Paulus R, Sandler HM.

Int J Radiat Oncol Biol Phys. 2019 Apr 6. pii: S0360-3016(19)30610-8. doi: 10.1016/j.ijrobp.2019.03.049. [Epub ahead of print]

PMID:
30959123
2.

Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone.

Rotman M, Hamdy NAT, Appelman-Dijkstra NM.

Br J Clin Pharmacol. 2019 Jun;85(6):1169-1179. doi: 10.1111/bcp.13820. Epub 2018 Dec 25. Review.

3.

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.

Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM.

Lancet Oncol. 2018 Nov;19(11):1504-1515. doi: 10.1016/S1470-2045(18)30528-X. Epub 2018 Oct 10. Erratum in: Lancet Oncol. 2018 Nov;19(11):e581.

PMID:
30316827
4.

Passive Coping Strategies Are Associated With More Impairment In Quality Of Life In Patients With Fibrous Dysplasia.

Rotman M, Andela CD, Majoor BCJ, Dijkstra PDS, Hamdy NAT, Kaptein AA, Appelman-Dijkstra NM.

Calcif Tissue Int. 2018 Nov;103(5):469-475. doi: 10.1007/s00223-018-0441-1. Epub 2018 Jun 13.

5.

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408.

Nichols RC, Hu C, Bahary JP, Zeitzer KL, Souhami L, Leibenhaut MH, Rotman M, Gore EM, Balogh AG, McGowan D, Michalski J, Raben A, Rudoler S, Jones CU, Sandler H.

Adv Radiat Oncol. 2017 Aug 3;2(4):608-614. doi: 10.1016/j.adro.2017.07.004. eCollection 2017 Oct-Dec.

6.

Illness Perceptions are Associated with Quality of Life in Patients with Fibrous Dysplasia.

Majoor BCJ, Andela CD, Quispel CR, Rotman M, Dijkstra PDS, Hamdy NAT, Kaptein AA, Appelman-Dijkstra NM.

Calcif Tissue Int. 2018 Jan;102(1):23-31. doi: 10.1007/s00223-017-0329-5. Epub 2017 Oct 11.

7.

Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.

Voog JC, Paulus R, Shipley WU, Smith MR, McGowan DG, Jones CU, Bahary JP, Zeitzer KL, Souhami L, Leibenhaut MH, Rotman M, Husain SM, Gore E, Raben A, Chafe S, Sandler HM, Efstathiou JA.

Eur Urol. 2016 Feb;69(2):204-10. doi: 10.1016/j.eururo.2015.08.027. Epub 2015 Sep 9.

8.

A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.

Rosenthal SA, Hunt D, Sartor AO, Pienta KJ, Gomella L, Grignon D, Rajan R, Kerlin KJ, Jones CU, Dobelbower M, Shipley WU, Zeitzer K, Hamstra DA, Donavanik V, Rotman M, Hartford AC, Michalski J, Seider M, Kim H, Kuban DA, Moughan J, Sandler H.

Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):294-302. doi: 10.1016/j.ijrobp.2015.05.024. Epub 2015 Jul 21.

9.

Camelid heavy chain only antibody fragment domain against β-site of amyloid precursor protein cleaving enzyme 1 inhibits β-secretase activity in vitro and in vivo.

Dorresteijn B, Rotman M, Faber D, Schravesande R, Suidgeest E, van der Weerd L, van der Maarel SM, Verrips CT, El Khattabi M.

FEBS J. 2015 Sep;282(18):3618-31. doi: 10.1111/febs.13367. Epub 2015 Jul 22.

10.

Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake.

Rotman M, Welling MM, van den Boogaard ML, Moursel LG, van der Graaf LM, van Buchem MA, van der Maarel SM, van der Weerd L.

Nucl Med Biol. 2015 Aug;42(8):695-702. doi: 10.1016/j.nucmedbio.2015.03.003. Epub 2015 Mar 18.

11.

Clinical and biochemical outcomes of men undergoing radical prostatectomy or radiation therapy for localized prostate cancer.

Schreiber D, Rineer J, Weiss JP, Safdieh J, Weiner J, Rotman M, Schwartz D.

Radiat Oncol J. 2015 Mar;33(1):21-8. doi: 10.3857/roj.2015.33.1.21. Epub 2015 Mar 31.

12.

Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neck.

Shenouda G, Zhang Q, Ang KK, Machtay M, Parliament MB, Hershock D, Suntharalingam M, Lin A, Rotman M, Nabid A, Hong S, Shehata S, Cmelak AJ, Sultanem K, Le QT.

Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):907-15. doi: 10.1016/j.ijrobp.2014.12.018. Epub 2015 Feb 7.

13.

Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease.

Rotman M, Welling MM, Bunschoten A, de Backer ME, Rip J, Nabuurs RJ, Gaillard PJ, van Buchem MA, van der Maarel SM, van der Weerd L.

J Control Release. 2015 Apr 10;203:40-50. doi: 10.1016/j.jconrel.2015.02.012. Epub 2015 Feb 7.

PMID:
25668771
14.

Radiation therapy for clinically localized prostate cancer: long-term results of 469 patients from a single institution in the era of dose escalation.

Surapaneni A, Schwartz D, Nwokedi E, Rineer J, Rotman M, Schreiber D.

J Cancer Res Ther. 2014 Oct-Dec;10(4):951-6. doi: 10.4103/0973-1482.138096.

15.

Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.

Pisansky TM, Hunt D, Gomella LG, Amin MB, Balogh AG, Chinn DM, Seider MJ, Duclos M, Rosenthal SA, Bauman GS, Gore EM, Rotman MZ, Lukka HR, Shipley WU, Dignam JJ, Sandler HM.

J Clin Oncol. 2015 Feb 1;33(4):332-9. doi: 10.1200/JCO.2014.58.0662. Epub 2014 Dec 22.

16.

Long-term tolerance and outcomes for dose escalation in early salvage post-prostatectomy radiation therapy.

Safdieh JJ, Schwartz D, Weiner J, Weiss JP, Rineer J, Madeb I, Rotman M, Schreiber D.

Radiat Oncol J. 2014 Sep;32(3):179-86. doi: 10.3857/roj.2014.32.3.179. Epub 2014 Sep 30.

17.

PHI-DAC: protein homology database through dihedral angle conservation.

Maatuk N, Glantz-Gashai Y, Rotman M, Baydany M, Fonar G, Shechvitz A, Shemer K, Peleg A, Reuveni E, Samson AO.

Bioinformatics. 2015 Jan 15;31(2):292-4. doi: 10.1093/bioinformatics/btu617. Epub 2014 Sep 23.

PMID:
25252780
18.

Dose-escalated radiation therapy with and without short-course androgen deprivation for intermediate-risk prostate cancer.

Schreiber D, Rineer J, Surapaneni A, Navo E, Agarwal M, Nwokedi E, Rotman M, Schwartz D.

Anticancer Res. 2014 Aug;34(8):4189-93.

PMID:
25075045
19.

Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.

Harari PM, Harris J, Kies MS, Myers JN, Jordan RC, Gillison ML, Foote RL, Machtay M, Rotman M, Khuntia D, Straube W, Zhang Q, Ang K.

J Clin Oncol. 2014 Aug 10;32(23):2486-95. doi: 10.1200/JCO.2013.53.9163. Epub 2014 Jul 7.

20.

Impact of race in a predominantly African-American population of patients with low/intermediate risk prostate cancer undergoing radical prostatectomy within an equal access care institution.

Schreiber D, Levy EB, Schwartz D, Rineer J, Wong A, Rotman M, Weiss JP.

Int Urol Nephrol. 2014 Oct;46(10):1941-6. doi: 10.1007/s11255-014-0773-3. Epub 2014 Jun 27.

PMID:
24969031
21.

Concordance Between Prostate Needle Biopsy and Surgical Histopathology in a Primarily African-American Population.

Agarwal M, Schwartz D, Weiss J, Chen SC, Chhabra A, Rotman M, Schreiber D.

Int J Surg Pathol. 2014 Aug;22(5):414-9. doi: 10.1177/1066896913513834. Epub 2013 Dec 15.

PMID:
24344156
22.

Outcomes and tolerance of human immunodeficiency virus--positive U.S. veterans undergoing dose-escalated external beam radiotherapy for localized prostate cancer.

Schreiber D, Chhabra A, Rineer J, Nabhani T, Katsoulakis E, Morkos R, Rotman M, Schwartz D.

Clin Genitourin Cancer. 2014 Apr;12(2):94-9. doi: 10.1016/j.clgc.2013.07.008. Epub 2013 Oct 28.

PMID:
24176940
23.

Racial and socioeconomic disparities in the selection of prostate brachytherapy.

Schreiber D, Chen SC, Rineer J, Weiss J, Rotman M, Schwartz D.

J Contemp Brachytherapy. 2013 Sep;5(3):139-43. doi: 10.5114/jcb.2013.37563. Epub 2013 Sep 12.

24.

A population-based comparison of overall and disease-specific survival following local excision or abdominoperineal resection for stage I rectal adenocarcinoma.

Olsheski M, Schwartz D, Rineer J, Wortham A, Sura S, Sugiyama G, Rotman M, Schreiber D.

J Gastrointest Cancer. 2013 Sep;44(3):305-12. doi: 10.1007/s12029-013-9493-7.

PMID:
23564262
25.

RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal.

Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, Haddock MG, Rotman M, Parikh PJ, Safran H, Willett CG.

Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):27-33. doi: 10.1016/j.ijrobp.2012.09.023. Epub 2012 Nov 12.

26.

Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.

Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom SS, Ang KK.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1198-205. doi: 10.1016/j.ijrobp.2012.05.008. Epub 2012 Jun 30.

27.

In vivo detection of amyloid-β deposits using heavy chain antibody fragments in a transgenic mouse model for Alzheimer's disease.

Nabuurs RJ, Rutgers KS, Welling MM, Metaxas A, de Backer ME, Rotman M, Bacskai BJ, van Buchem MA, van der Maarel SM, van der Weerd L.

PLoS One. 2012;7(6):e38284. doi: 10.1371/journal.pone.0038284. Epub 2012 Jun 4.

28.

Characterization and outcomes of small cell carcinoma of the bladder using the surveillance, epidemiology, and end results database.

Schreiber D, Rineer J, Weiss J, Leaf A, Karanikolas N, Rotman M, Schwartz D.

Am J Clin Oncol. 2013 Apr;36(2):126-31. doi: 10.1097/COC.0b013e3182438c71.

PMID:
22391430
29.

Radiotherapy and short-term androgen deprivation for localized prostate cancer.

Jones CU, Hunt D, McGowan DG, Amin MB, Chetner MP, Bruner DW, Leibenhaut MH, Husain SM, Rotman M, Souhami L, Sandler HM, Shipley WU.

N Engl J Med. 2011 Jul 14;365(2):107-18. doi: 10.1056/NEJMoa1012348.

30.

Pre-clinical optical imaging and MRI for drug development in Alzheimer's disease.

Rotman M, Snoeks TJ, van der Weerd L.

Drug Discov Today Technol. 2011 Summer;8(2-4):e117-25. doi: 10.1016/j.ddtec.2011.11.005.

PMID:
24990260
31.

Transmigration of beta amyloid specific heavy chain antibody fragments across the in vitro blood-brain barrier.

Rutgers KS, Nabuurs RJ, van den Berg SA, Schenk GJ, Rotman M, Verrips CT, van Duinen SG, Maat-Schieman ML, van Buchem MA, de Boer AG, van der Maarel SM.

Neuroscience. 2011 Sep 8;190:37-42. doi: 10.1016/j.neuroscience.2011.05.076. Epub 2011 Jun 13.

PMID:
21683126
32.

Impact of adjuvant external-beam radiation therapy in early-stage uterine papillary serous and clear cell carcinoma.

Kim A, Schreiber D, Rineer J, Choi K, Rotman M.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e639-44. doi: 10.1016/j.ijrobp.2011.01.053. Epub 2011 Apr 18.

PMID:
21507584
33.

Impact of postoperative radiation on survival for high-grade soft tissue sarcoma of the extremities after limb sparing radical resection.

Schreiber D, Rineer J, Katsoulakis E, Sroufe RL, Lange CS, Nwokedi E, Schwartz D, Choi K, Rotman M.

Am J Clin Oncol. 2012 Feb;35(1):13-7. doi: 10.1097/COC.0b013e3181fe46d4.

PMID:
21278563
34.

Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215.

Watkins Bruner D, James JL, Bryan CJ, Pisansky TM, Rotman M, Corbett T, Speight J, Byhardt R, Sandler H, Bentzen S, Kachnic L, Berk L.

J Sex Med. 2011 Apr;8(4):1228-38. doi: 10.1111/j.1743-6109.2010.02164.x. Epub 2011 Jan 14.

35.

Radical prostatectomy for cT3-4 disease: an evaluation of the pathological outcomes and patterns of care for adjuvant radiation in a national cohort.

Schreiber D, Rineer J, Sura S, Teper E, Nabhani T, Han P, Schwartz D, Choi K, Rotman M.

BJU Int. 2011 Aug;108(3):360-5. doi: 10.1111/j.1464-410X.2010.09875.x. Epub 2010 Nov 18.

36.

Analysis of pathologic extent of disease for clinically localized prostate cancer after radical prostatectomy and subsequent use of adjuvant radiation in a national cohort.

Schreiber D, Rineer J, Yu JB, Olsheski M, Nwokedi E, Schwartz D, Choi K, Rotman M.

Cancer. 2010 Dec 15;116(24):5757-66. doi: 10.1002/cncr.25561. Epub 2010 Aug 24.

37.

Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma.

Chung CH, Zhang Q, Hammond EM, Trotti AM 3rd, Wang H, Spencer S, Zhang HZ, Cooper J, Jordan R, Rotman MH, Ang KK.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):331-8. doi: 10.1016/j.ijrobp.2010.05.024. Epub 2010 Aug 21.

38.

Characterization and outcomes of infratentorial malignant glioma: a population-based study using the Surveillance Epidemiology and End-Results database.

Rineer J, Schreiber D, Choi K, Rotman M.

Radiother Oncol. 2010 Jun;95(3):321-6. doi: 10.1016/j.radonc.2010.04.007. Epub 2010 May 5.

PMID:
20451276
39.

Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315.

Zachariah B, Gwede CK, James J, Ajani J, Chin LJ, Donath D, Rosenthal SA, Kane BL, Rotman M, Berk L, Kachnic LA.

J Natl Cancer Inst. 2010 Apr 21;102(8):547-56. doi: 10.1093/jnci/djq063. Epub 2010 Mar 25.

40.

Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?

Schreiber D, Rineer J, Weedon J, Vongtama D, Wortham A, Kim A, Han P, Choi K, Rotman M.

Cancer. 2010 Mar 1;116(5):1350-7. doi: 10.1002/cncr.24853.

41.

Impact of postoperative radiation after esophagectomy for esophageal cancer.

Schreiber D, Rineer J, Vongtama D, Wortham A, Han P, Schwartz D, Choi K, Rotman M.

J Thorac Oncol. 2010 Feb;5(2):244-50. doi: 10.1097/JTO.0b013e3181c5e34f.

42.

Survival following sublobar resection for early-stage non-small cell lung cancer with or without adjuvant external beam radiation therapy: a population-based study.

Rineer J, Schreiber D, Katsoulakis E, Nabhani T, Han P, Lange C, Choi K, Rotman M.

Chest. 2010 Feb;137(2):362-8. doi: 10.1378/chest.09-0868. Epub 2009 Sep 11.

PMID:
19749007
43.

Effective treatment of the brachial plexus syndrome in breast cancer patients by early detection and control of loco-regional metastases with radiation or systemic therapy.

Kamenova B, Braverman AS, Schwartz M, Sohn C, Lange C, Efiom-Ekaha D, Rotman M, Yoon H.

Int J Clin Oncol. 2009 Jun;14(3):219-24. doi: 10.1007/s10147-008-0838-3. Epub 2009 Jul 11.

PMID:
19593613
44.

MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.

Khor LY, Bae K, Paulus R, Al-Saleem T, Hammond ME, Grignon DJ, Che M, Venkatesan V, Byhardt RW, Rotman M, Hanks GE, Sandler HM, Pollack A.

J Clin Oncol. 2009 Jul 1;27(19):3177-84. doi: 10.1200/JCO.2008.19.8267. Epub 2009 May 26.

45.

Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck.

Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, Rotman M, Meredith R, Ang KK.

Head Neck. 2008 Mar;30(3):281-8.

PMID:
17764087
46.

Microvessel density >or=60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial.

Calvin DP, Hammond ME, Pajak TF, Trotti AM, Meredith RF, Rotman M, Jones CU, Byhardt RW, Demas WF, Ang KK, Fu KK; Radiation Therapy Oncology Group 90-03 Trial.

Am J Clin Oncol. 2007 Aug;30(4):406-19.

PMID:
17762442
47.

An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions.

Lawton CA, DeSilvio M, Roach M 3rd, Uhl V, Kirsch R, Seider M, Rotman M, Jones C, Asbell S, Valicenti R, Hahn S, Thomas CR Jr.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):646-55. Epub 2007 May 24.

48.

Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trial.

Roach M 3rd, De Silvio M, Rebbick T, Grignon D, Rotman M, Wolkov H, Fisher B, Hanks G, Shipley WU, Pollack A, Sandler H, Watkins-Bruner D.

Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):79-87. Epub 2007 May 10.

PMID:
17498886
49.

Validity and reliability of the Community Integration Program Questionnaire.

Glenn M, Goldstein R, Selleck E, Rotman M, Jacob L.

Int J Rehabil Res. 2006 Jun;29(2):117-21.

PMID:
16609322
50.

A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study.

Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, Zaino RJ.

Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):169-76. Epub 2006 Jan 19.

PMID:
16427212

Supplemental Content

Loading ...
Support Center